EGFR and central nervous system cancer: Activated EGFR increased the production of tumor‐derived VEGF that acts on endothelial cells in a paracrine manner to promote angiogenesis (Larsen et al., 2011) and amplification of EGFR also indicated poor prognosis in glioma (Sun et al., 2014) (Fig. 7G).